Organo <6368> has a high stop. Financial results for the first half of the year were announced last weekend, and operating profit was 11.5 billion yen, up 46.1% from the same period last year, which is above the previous forecast of 9.5 billion yen. The full-year forecast was raised from the previous 24.5 billion yen to 28 billion yen, an increase of 24.2% from the previous fiscal year, and has been revised upward following the first quarter financial results. The annual dividend will also be raised from the previous plan of 106 yen to 142 yen, increasing dividends by 40 yen compared to the previous fiscal year. The increase in sales in the relatively profitable solution business seems to be the main reason for the increase in earnings.
オルガノ---ストップ高、第1四半期決算時に続く業績上方修正
Organoid - Stock hits upper limit, performance revised upwards following first quarter earnings announcement.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.